Showing 5,805 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

PrEP science

Daily PrEP is safe for the kidneys, although on-demand PrEP has slightly less impact

News
30 December 2022
Pharmaceutical industry

CytoDyn’s former CEO indicted for securities fraud. His misleading statements hurt patients even more than investors

Editor's pick
STAT
26 December 2022
Pharmaceutical industry

Ex-Cytodyn CEO, Amarex CEO hit with multiple fraud charges

Editor's pick
FierceBiotech
26 December 2022
Injectable & long-acting HIV treatment

Injectable HIV treatment offers hope to Ugandan patients

Editor's pick
Reuters
26 December 2022
Weight gain & lipodystrophy

Switching from TAF to older tenofovir may halt or reverse weight gain and lipid increases

News
23 December 2022
Injectable & long-acting HIV treatment

FDA Approves New HIV Drug for Adults with Limited Treatment Options

Editor's pick
FDA
22 December 2022
Activism & civil society

Helping HIV Treatment ‘Defaulters’ in Cameroon Stay the Course

Editor's pick
TheBody
19 December 2022
Epidemiology

Russia Dismisses Data Showing World's 5th-Highest HIV Infection Rate

Editor's pick
The Moscow Times
8 December 2022
Injectable & long-acting HIV treatment

The people who need injectable HIV drugs most are the ones who can’t get them, BHIVA told

News
7 December 2022
Injectable & long-acting HIV treatment

Pregnancy Outcomes on Long-Acting Antiretroviral

Editor's pick
Medscape (requires free registration)
6 December 2022
HIV treatment for children & young people

European Commission Grants Expanded Marketing Authorization for Gilead’s Biktarvy® for the Treatment of HIV in Pediatric Populations

Editor's pick
Gilead Sciences press release
29 November 2022
Treatment outcomes & life expectancy

People living with HIV still at higher risk of death by suicide, accident, violence, and substance use

News
29 November 2022
Injectable & long-acting HIV treatment

Botswana Introduces Injectable Antiretrovirals for HIV Treatment

Editor's pick
AllAfrica
23 November 2022
Treatment outcomes & life expectancy

Almost as many healthy years for people with undetectable HIV as HIV-negative people in South Africa

News
21 November 2022
Climate change

'I missed a dose for the first time': How the KZN floods derailed HIV treatment

Editor's pick
Bhekisisa
17 November 2022
Changing treatment

Second-line HIV treatment durable for eight years in Uganda

News
17 November 2022
Climate change

How Climate Change Is Impacting People Living With HIV and Medication Access in South Africa

Editor's pick
TheBody
12 November 2022
Antibody-based treatment

Do broadly neutralising antibodies really have a future in treating HIV?

News
11 November 2022
Injectable & long-acting HIV treatment

Lenacapavir Shows Continued Promise for People With Drug-Resistant HIV

Editor's pick
POZ
10 November 2022
HIV treatment

IDWeek 2022 Study Bites: What’s New in HIV Antiretroviral Therapy

Editor's pick
TheBodyPro
10 November 2022
Adherence

Tenofovir Detected in Urine Predicts HIV Viral Rebound, Drug Resistance

Editor's pick
Infectious Disease Advisor
9 November 2022
Weight gain & lipodystrophy

Obesity Risk Higher With DTG Than Other Regimens in 3 Big African Trials

Editor's pick
NATAP
1 November 2022
Pharmaceutical industry

Long-suffering CytoDyn withdraws HIV approval application for leronlimab, blaming clinical research organization

Editor's pick
FierceBiotech
1 November 2022
Injectable & long-acting HIV treatment

Who is at risk of injectable treatment failure?

News
1 November 2022